Pyrazolotriazines as CRF antagonists

摘要

The present invention relates to pyrazolotriazines according to formula (I) and stereoisomers, isomers and salts thereof wherein R<1>-R<5 >are selected from certain alkyl, aryl and heteroaryl species as defined in the specification wherein all of the compounds are useful as CRF antagonists and are thus useful in the treatment of neurological disorders as well as a multitude of other CRF associated diseases or conditions.